NCT06538649View on ClinicalTrials.gov

Effect of Statins on Crohn's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Crohn's IleocolitisCrohn Disease
Interventions
DRUG

Rosuvastatin

Rosuvastatin provided at 10 mg start; 5mg for Asians. Dose will be increased to 20 mg for those tolerating and without contraindication.

OTHER

Placebo

Placebo tablet(s)

Trial Locations (1)

94305

RECRUITING

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER